Hospital
MH Blue Ridge Medical Center, LLLP
MH Blue Ridge Medical Center, LLLP was paid $6.27M by Medicaid between Feb 2019 and Dec 2024, across 101 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoMH BLUE RIDGE MEDICAL CENTER, LLLP
SPRUCE PINE, NC 28777
SPRUCE PINE, NC 28777
33aNPI1578048294assigned 09/27/2018
33bProvider typeRural Acute Care Hospital
28Total paid$6.27M
24GClaims127,422
24DCodes billed101
24AFirst – last monthFeb 2019 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 20,728 | $773K | |
| 2020 | 23,822 | $1.05M | |
| 2021 | 22,725 | $1.16M | |
| 2022 | 20,939 | $1.04M | |
| 2023 | 24,895 | $1.24M | |
| 2024incomplete | 14,313 | $1.00M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 10,529 | 9,456 | $1.66M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 25% | 7,198 | 6,204 | $1.55M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11% | 1,047 | 924 | $703K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.2% | 1,936 | 1,582 | $451K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.7% | 999 | 875 | $235K |
| 71045 | Radiologic examination, chest; single view | 2.8% | 3,945 | 3,450 | $173K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.4% | 3,466 | 3,247 | $151K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.0% | 3,609 | 2,993 | $128K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 1,745 | 1,544 | $125K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.5% | 1,641 | 1,495 | $94K |
| 80053 | Comprehensive metabolic panel | 1.4% | 11,703 | 9,760 | $85K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 1.3% | 2,729 | 2,440 | $83K |
89 more codes
| 85027 | 1.2% | 13,806 | $76K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 2,118 | $67K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,588 | $61K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,851 | $51K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,104 | $47K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,179 | $37K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 664 | $36K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 83 | $36K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 1,515 | $29K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,258 | $28K |
| 87634 | <1% | 473 | $24K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 458 | $21K |
| 81001 | <1% | 6,588 | $19K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 9,162 | $17K |
| 84484 | <1% | 2,932 | $17K | |
| 83880 | <1% | 939 | $15K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,473 | $15K |
| G0378 | Hospital observation service, per hour | <1% | 108 | $14K |
| 80061 | Lipid panel | <1% | 1,334 | $13K |
| 83690 | <1% | 2,113 | $11K | |
| 73564 | <1% | 225 | $11K | |
| 96376 | <1% | 292 | $10K | |
| 83605 | <1% | 1,445 | $10K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,755 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,364 | $9K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 391 | $9K |
| 83735 | <1% | 2,157 | $9K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,460 | $8K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 180 | $6K |
| 87040 | <1% | 925 | $6K | |
| 73110 | <1% | 164 | $6K | |
| 87077 | <1% | 854 | $6K | |
| 87186 | <1% | 791 | $5K | |
| 74018 | <1% | 129 | $5K | |
| 73630 | <1% | 114 | $5K | |
| 73610 | <1% | 122 | $5K | |
| 80306 | <1% | 337 | $5K | |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 31 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 179 | $4K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 103 | $4K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 167 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 166 | $4K |
| 73030 | <1% | 120 | $4K | |
| 81025 | <1% | 552 | $3K | |
| 85610 | <1% | 1,468 | $3K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 242 | $3K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 157 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $3K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 12 | $3K |
| 86780 | <1% | 262 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 340 | $2K |
| 97162 | <1% | 133 | $2K | |
| 84703 | <1% | 293 | $2K | |
| 72100 | <1% | 45 | $2K | |
| 73130 | <1% | 42 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 13 | $1K |
| 73502 | <1% | 33 | $1K | |
| 86850 | <1% | 167 | $1K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 36 | $1K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 19 | $1K |
| 85730 | <1% | 379 | $1K | |
| 86703 | <1% | 130 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 345 | $1K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 14 | $981.54 |
| 85379 | <1% | 137 | $925.34 | |
| J3490 | Unclassified drugs | <1% | 940 | $920.92 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 186 | $818.42 |
| 86803 | <1% | 68 | $732.92 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 12 | $675.45 |
| 82607 | <1% | 46 | $666.09 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 277 | $614.27 |
| 84439 | <1% | 78 | $467.99 | |
| 86140 | <1% | 88 | $391.80 | |
| 86901 | <1% | 177 | $373.97 | |
| 86900 | <1% | 177 | $373.30 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 26 | $265.32 |
| 84702 | <1% | 33 | $263.90 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 74 | $200.09 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 27 | $181.17 |
| 87340 | <1% | 13 | $133.87 | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 214 | $111.47 |
| 85652 | <1% | 41 | $91.36 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 22 | $83.95 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 76 | $24.81 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 19 | $18.48 |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 0% | 26 | $0.00 |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 0% | 30 | $0.00 |
| 82077 | 0% | 13 | $0.00 | |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 164 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHALE, TONIA (CEO)
| Provider | Location | Paid |
|---|---|---|
| MH Blue Ridge Medical Center, LLLP | Spruce Pine, NC | $6K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.